| Financial Year |
March 31 2020 |
| Monetary Funds |
73,920,371.83 |
| Held-for-trading Financial Assets |
4,340,890.46 |
| Notes Receivable |
-- |
| Accounts Receivable |
1,213,143,648.25 |
| Advances to Suppliers |
48,357,654.72 |
| Other Receivables |
136,352,300.84 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
337,438,250.73 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
246,832,976.04 |
| Total Current Assets |
4,615,832,605.64 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
3,088,711.49 |
| Long-term Equity Investment |
200,614,737.44 |
| Investment Properties |
35,131,637.80 |
| Fixed Assetes |
815,982,147.88 |
| Under-construction Projects |
45,554,404.08 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
152,272,282.71 |
| R&D expenses |
-- |
| Goodwill |
25,222,874.38 |
| Long-Term Deferred and Prepaid Expenses |
1,150,644.50 |
| Deferred Income Tax Assets |
59,382,413.80 |
| Other Non-Current Assets |
16,603,998.45 |
| Sub-Total of Non-Current Assets |
1,374,356,720.23 |
| Total Assets |
5,990,189,325.87 |
| Short-Term Loans |
248,018,744.86 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
2,075,986,859.48 |
| Accounts Received In Advance |
69,322,497.76 |
| Employee Compensation Payable |
46,551,283.30 |
| Taxes Payable |
98,956,423.33 |
| Interest Payable |
90,584,783.71 |
| Dividend Payable |
7,895,426.24 |
| Other payables |
267,443,837.20 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,225,000,000.00 |
| Other Current Liabilities |
228,696,695.59 |
| Sub-Total of Current Liabilities |
4,274,645,112.48 |
| Long-term Loans |
70,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
48,000,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
18,222,720.78 |
| Deferred Income Tax Liabilities |
1,018,190.35 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
143,378,758.48 |
| Total Liabilities |
4,418,023,870.96 |
| Paid-In Capital(Or Share Stock) |
2,492,492,696.00 |
| Capital Surplus |
1,224,694,051.74 |
| Surplus Reserve |
58,794,843.89 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-2,288,079,787.92 |
| Minority Stockholder's Interest |
61,713,913.13 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,510,451,541.78 |
| Owner's Equity（Stockholder's Equity） |
1,572,165,454.91 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,990,189,325.87 |
